€869,985
▼ Sales (10 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Bellon Christine. Officer active across 1 company, notably Beam Therapeutics Inc.. Cumulatively, 15 disclosures have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €870k. Activity tracked since 30 March 2023. The latest transaction was disclosed on 15 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
2,111 shares@ US$33.62196.1% of flowCommon StockSEC:0001193125-26-016552:0
15,959 shares@ US$34.718247.4% of flowCommon StockSEC:0001193125-26-016552:1
559 shares@ US$35.39881.7% of flowCommon StockSEC:0001193125-26-016552:2
5,674 shares@ US$18.35079.6% of flowCommon StockSEC:0000950170-25-050859:0
20,000 shares0Common StockSEC:0000950170-25-049769:0
9,492 shares@ US$7.226.5% of flowCommon StockSEC:0000950170-25-023166:0
1,241 shares@ US$24.682.9% of flowCommon StockSEC:0000950170-25-002358:0
385 shares@ US$23.47940.8% of flowCommon StockSEC:0000950170-24-111739:0
3,401 shares@ US$32.1210.1% of flowCommon StockSEC:0000950170-24-041438:0
27,500 shares0Common StockSEC:0000950170-24-040150:0
1,907 shares@ US$26.424.6% of flowCommon StockSEC:0000950170-24-002480:0
4,182 shares@ US$7.222.8% of flowCommon StockSEC:0000950170-23-065868:0
388 shares@ US$22.850.8% of flowCommon StockSEC:0000950170-23-051915:0
931 shares@ US$30.312.6% of flowCommon StockSEC:0000899243-23-010817:0
6,272 shares@ US$7.224.1% of flowCommon StockSEC:0000899243-23-010140:0